Yıl: 2022 Cilt: 28 Sayı: 5 Sayfa Aralığı: 463 - 469 Metin Dili: İngilizce DOI: 10.5152/dir.2022.211228 İndeks Tarihi: 09-11-2022

The value of adjacent vessel sign in malignant breast tumors

Öz:
PURPOSE The aim of this study was to evaluate the prognostic quality of adjacent vessel sign (AVS) in malignant breast tumors by comparing it with classical prognostic pathological biomarkers and magnetic resonance imaging (MRI) findings. METHODS A total of 124 patients with 133 malignant lesions were included. All the imaging was performed on a 1.5T Avanto scanner and the images were interpreted according to BI-RADS-MR® (fifth ed.) atlas. Maximum intensity projection (MIP) images were constructed from subtracted post-con trast images and were used to investigate AVS. Histopathological results and MRI findings were compared with AVS. RESULTS Interobserver agreement about AVS status was substantial (κ=0.64). AVS positive lesions were significantly bigger in size (P < .001, AVS negative: median 12 mm, AVS positive: median 31 mm). AVS was significantly associated with increased Ki-67 index and axillary lymph node metasta sis (P=.009 and P=.019, respectively). Between AVS and lymphovascular invasion (LVI), there was a trend toward positive relationship (P=.076). MRI findings of T2 hypointensity, peritu moral edema, irregular shape, non-homogeneous contrast enhancement, rapid early contrast enhancement, and skin infiltration showed significant positive relation with AVS (P < .001, P < .001, P < .001, P=.02, P=.021, and P=.021, respectively). AVS is found to be associated with increased Ki-67 index, axillary lymph node metastasis, and some MRI findings that point to malignancy or poor prognosis. CONCLUSION AVS indicates poor prognosis since it is related to axillary lymph node metastasis, increased Ki-67 index, LVI, peritumoral edema, rapid early contrast enhancement, increased background enhancement, skin extension, T2 hypointensity, non-homogeneous contrast enhancement, irregular lesion shape, and larger tumor size. AVS is an easy to use sign that shows substantial interobserver agreement.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108. [CrossRef]
  • 2. Szabó BK, Aspelin P, Kristoffersen Wiberg MK, Tot T, Boné B. Invasive breast cancer: correla tion of dynamic MR features with prognostic factors. Eur Radiol. 2003;13(11):2425-2435. [CrossRef]
  • 3. Teifke A, Behr O, Schmidt M, et al. Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis. Radiology. 2006;239(2):351-360. [CrossRef]
  • 4. Han M, Kim TH, Kang DK, Kim KS, Yim H. Prog nostic role of MRI enhancement features in patients with breast cancer: value of adjacent vessel sign and increased ipsilateral whole breast vascularity. AJR Am J Roentgenol. 2012;199(4):921-928. [CrossRef]
  • 5. Frouge C, Guinebretière JM, Contesso G, Di Paola RP, Bléry M. Correlation between con trast enhancement in dynamic magnetic reso nance imaging of the breast and tumor angio genesis. Invest Radiol. 1994;29(12):1043-1049. [CrossRef]
  • 6. Mahfouz AE, Sherif H, Saad A, et al. Gadolin ium- enhanced MR angiography of the breast: is breast cancer associated with ipsilateral higher vascularity? Eur Radiol. 2001;11(6):965- 969. [CrossRef]
  • 7. Wright H, Listinsky J, Quinn C, Rim A, Crowe J, Kim J. Increased ipsilateral whole breast vascu larity as measured by contrast-enhanced mag netic resonance imaging in patients with breast cancer. Am J Surg. 2005;190(4):576-579. [CrossRef]
  • 8. Kim JY, Kim SH, Kim YJ, et al. Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognos tic factors and subtypes of breast cancers? Magn Reson Imaging. 2015;33(1):72-80. [CrossRef]
  • 9. Sardanelli F, Fausto A, Menicagli L, Esseri dou A. Breast vascular mapping obtained with contrast-enhanced MR imaging: impli cations for cancer diagnosis, treatment, and risk stratification. Eurradiol Suppl. 2007;17(6):48-51.
  • 10. Verardi N, Di Leo G, Carbonaro LA, Fedeli MP, Sardanelli F. Contrast-enhanced MR imaging of the breast: association between asymmet ric increased breast vascularity and ipsilat eral cancer in a consecutive series of 197 patients. Radiol Med. 2013;118(2):239-250. [CrossRef]
  • 11. Carriero A, Di Credico A, Mansour M, Bonomo L. Maximum intensity projection analysis in mag netic resonance of the breast. J Exp Clin Cancer Res. 2002;21(3):77-81.
  • 12. Kul S, Cansu A, Alhan E, Dinc H, Reis A, Çan G. Contrast-enhanced MR angiography of the breast: evaluation of ipsilateral increased vascu larity and adjacent vessel sign in the characteri zation of breast lesions. AJR Am J Roentgenol. 2010;195(5):1250-1254. [CrossRef]
  • 13. Dietzel M, Baltzer PA, Vag T, et al. The adjacent vessel sign on breast MRI: new data and a sub group analysis for 1,084 histologically verified cases. Korean J Radiol. 2010;11(2):178-186. [CrossRef]
  • 14. Choi EJ, Choi H, Choi SA, Youk JH. Dynamic contrast-enhanced breast magnetic reso nance imaging for the prediction of early and late recurrences in breast cancer. Medicine. 2016;95(48):e5330. [CrossRef]
  • 15. Boström P. Prognostic Factors in Breast Cancer. With Special Reference to Cyclins A, B1, D1 and E, MMP-1 and Decorin. 2014:20-22.
  • 16. Lakhani SR. WHO Classification of Tumours of the Breast. Lyon: IARC; 2012.
  • 17. Bustreo S, Osella-Abate S, Cassoni P, et al. Opti mal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up. Breast Cancer Res Treat. 2016;157(2):363-371. [CrossRef]
  • 18. Hoda SA. Assessment of prognosis with mor phologic and biologic markers. In: Hoda SA, ed. Rosen’s Breast Pathology. USA: Lippincott Williams & Wilkins-Wolters Kluwer Health; 2014:413-468.
  • 19. Eble JN, Tavassoli FA, Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC; 2003.
  • 20. Cheon H, Kim HJ, Lee SM, et al. Preoperative MRI features associated with lymphovascular inva sion in node-negative invasive breast cancer: a propensity matched analysis. J Magn Reson Imaging. 2017;46(4):1037-1044. [CrossRef]
  • 21. Mamma BR, In Remmele W, editor. Pathologie. Berlin: Springer; 1997. pp. 135–365.
  • 22. Choi JS, Ko ES, Ko EY, Han BK, Nam SJ. Back ground parenchymal enhancement on preop erative magnetic resonance imaging: associa tion with recurrence-free survival in breast cancer patients treated with neoadjuvant chemotherapy. Medicine. 2016;95(9):e3000. [CrossRef]
  • 23. Yuen S, Uematsu T, Kasami M, et al. Breast carci nomas with strong high-signal intensity on T2 weighted MR images: pathological charac teristics and differential diagnosis. J Magn Reson Imaging. 2007;25(3):502-510. [CrossRef]
  • 24. Baltzer PA, Dietzel M, Kaiser WA. Nonmass lesions in magnetic resonance imaging of the breast: additional T2-weighted images improve diagnostic accuracy. J Comput Assist Tomogr. 2011;35(3):361-366. [CrossRef]
  • 25. Fischer DR, Malich A, Wurdinger S, Boettcher J, Dietzel M, Kaiser WA. The adjacent vessel on dynamic contrast-enhanced breast MRI. AJR Am J Roentgenol. 2006;187(2):W147-W151. [CrossRef]
  • 26. Song SE, Shin SU, Moon HG, Ryu HS, Kim K, Moon WK. MR imaging features associated with distant metastasis-free survival of patients with invasive breast cancer: a case–control study. Breast Cancer Res Treat. 2017;162(3):559- 569. [CrossRef]
  • 27. Shin HJ, Kim HH, Shin KC, et al. Prediction of low-risk breast cancer using perfusion param eters and apparent diffusion coefficient. Magn Reson Imaging. 2016;34(2):67-74. [CrossRef]
  • 28. Caiazzo C, Di Micco RD, Esposito E, et al. The role of MRI in predicting Ki-67 in breast cancer: preliminary results from a prospective study. Tumori. 2018;104(6):438-443. [CrossRef]
  • 29. MorrisE, Comstock C, Lee C, Lehman C, Ikeda D. ACR BI-RADS® magnetic resonance imaging. ACR BI-RADS® atlas, Breast Imaging Reporting and Data System Reston, VA. J Am Collradiol. 2013:56-71.
APA c e, YILDIZ Ş, Otcu Temur H, Sharifov R, Yabul F, ALKAN A (2022). The value of adjacent vessel sign in malignant breast tumors. , 463 - 469. 10.5152/dir.2022.211228
Chicago c ezra,YILDIZ Şeyma,Otcu Temur Hafize,Sharifov Rasul,Yabul Fatma,ALKAN ALPAY The value of adjacent vessel sign in malignant breast tumors. (2022): 463 - 469. 10.5152/dir.2022.211228
MLA c ezra,YILDIZ Şeyma,Otcu Temur Hafize,Sharifov Rasul,Yabul Fatma,ALKAN ALPAY The value of adjacent vessel sign in malignant breast tumors. , 2022, ss.463 - 469. 10.5152/dir.2022.211228
AMA c e,YILDIZ Ş,Otcu Temur H,Sharifov R,Yabul F,ALKAN A The value of adjacent vessel sign in malignant breast tumors. . 2022; 463 - 469. 10.5152/dir.2022.211228
Vancouver c e,YILDIZ Ş,Otcu Temur H,Sharifov R,Yabul F,ALKAN A The value of adjacent vessel sign in malignant breast tumors. . 2022; 463 - 469. 10.5152/dir.2022.211228
IEEE c e,YILDIZ Ş,Otcu Temur H,Sharifov R,Yabul F,ALKAN A "The value of adjacent vessel sign in malignant breast tumors." , ss.463 - 469, 2022. 10.5152/dir.2022.211228
ISNAD c, ezra vd. "The value of adjacent vessel sign in malignant breast tumors". (2022), 463-469. https://doi.org/10.5152/dir.2022.211228
APA c e, YILDIZ Ş, Otcu Temur H, Sharifov R, Yabul F, ALKAN A (2022). The value of adjacent vessel sign in malignant breast tumors. Diagnostic and Interventional Radiology, 28(5), 463 - 469. 10.5152/dir.2022.211228
Chicago c ezra,YILDIZ Şeyma,Otcu Temur Hafize,Sharifov Rasul,Yabul Fatma,ALKAN ALPAY The value of adjacent vessel sign in malignant breast tumors. Diagnostic and Interventional Radiology 28, no.5 (2022): 463 - 469. 10.5152/dir.2022.211228
MLA c ezra,YILDIZ Şeyma,Otcu Temur Hafize,Sharifov Rasul,Yabul Fatma,ALKAN ALPAY The value of adjacent vessel sign in malignant breast tumors. Diagnostic and Interventional Radiology, vol.28, no.5, 2022, ss.463 - 469. 10.5152/dir.2022.211228
AMA c e,YILDIZ Ş,Otcu Temur H,Sharifov R,Yabul F,ALKAN A The value of adjacent vessel sign in malignant breast tumors. Diagnostic and Interventional Radiology. 2022; 28(5): 463 - 469. 10.5152/dir.2022.211228
Vancouver c e,YILDIZ Ş,Otcu Temur H,Sharifov R,Yabul F,ALKAN A The value of adjacent vessel sign in malignant breast tumors. Diagnostic and Interventional Radiology. 2022; 28(5): 463 - 469. 10.5152/dir.2022.211228
IEEE c e,YILDIZ Ş,Otcu Temur H,Sharifov R,Yabul F,ALKAN A "The value of adjacent vessel sign in malignant breast tumors." Diagnostic and Interventional Radiology, 28, ss.463 - 469, 2022. 10.5152/dir.2022.211228
ISNAD c, ezra vd. "The value of adjacent vessel sign in malignant breast tumors". Diagnostic and Interventional Radiology 28/5 (2022), 463-469. https://doi.org/10.5152/dir.2022.211228